U.S. Department of Health and Human Services partners with Regeneron Pharmaceuticals Inc to develop coronavirus therapy
The U.S. Department of Health and Human Services has partnered with Regeneron Pharmaceuticals Inc to develop a treatment for the coronavirus whose outbreak in China has killed hundreds of people in China alone. The drugmaker collaboration with the U.S. Department of Health and Human Services is the latest to join the race to develop a…
